Study of Acthar® Gel (Acthar) for Amyotrophic Lateral Sclerosis (ALS)

NCT03068754 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

143

Enrollment

INDUSTRY

Sponsor class

Stopped As recommended by the study's independent Data and Safety Monitoring Board (DSMB)

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Acthar
DRUG: Placebo

Sponsor

Mallinckrodt